Cantitate/Preț
Produs
Total produse
Vezi coșul
Biosimilar Drug Product Development de Laszlo Endrenyi

Biosimilar Drug Product Development: Drugs and the Pharmaceutical Sciences

Editat de Laszlo Endrenyi, Dr. Paul Declerck, Shein-Chung Chow
en Limba Engleză Paperback – 30 iun 2020
When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 41568 lei  6-8 săpt.
  CRC Press – 30 iun 2020 41568 lei  6-8 săpt.
Hardback (1) 128913 lei  6-8 săpt.
  CRC Press – 7 mar 2017 128913 lei  6-8 săpt.

Din seria Drugs and the Pharmaceutical Sciences

Preț: 41568 lei

Preț vechi: 58453 lei
-29% Nou

Puncte Express: 624
Preț estimativ în valută:
7357€ • 8628$ • 6450£

Carte tipărită la comandă

Livrare economică 27 ianuarie-10 februarie 26

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780367552497
ISBN-10: 0367552493
Pagini: 496
Ilustrații: 90
Dimensiuni: 156 x 234 x 27 mm
Greutate: 0.7 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Drugs and the Pharmaceutical Sciences

Public țintă

Academic and Professional Practice & Development

Cuprins

Analytical characterization. Immunogenicity. Animal studies. Clinical development. Manufacturing, process control. Extrapolation of indications. Interchangeability, substitution. Pharmacovigilance. Statistical issues. Regulatory issues.

Descriere

When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.